The end of the boom years has been signalled for pharma, with an anticipated dip in growth to just 1.3% to 2015, according to research from Datamonitor. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/pharma_growth_expected_to_slow_979734Tomorrow is the big day – 7 May; UK General Election day. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/undecided_who_to_vote_for_in_the_uk_general_election_971378The pharmaceutical supply chain is facing both challenges and opportunities as the industry enters a new healthcare era 26 PharmaTimes - Magazine Article - PharmaTimes
by Katrina Megget
www.pharmatimes.com/magazine/2017/june/supplying_for_tomorrows_needsIt’s all change again in the fight for Salix Pharmaceuticals – last week’s $11 billion bid by Endo International has been binned in favour of rival bidder Valeant Pharmaceuticals International, which has put forward a revised $173-a-share offer. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/valeant_counterbids_for_salix_971189There’s ever-increasing menu of tools, technologies and tactics to choose from, but is pharma ready to innovate? - Magazine Article - PharmaTimes
by Katrina Megget
www.pharmatimes.com/magazine/2017/may/marketing_outside_the_boxUK plans to fast track access to drugs – in some cases up to ten years earlier – are expected to be announced imminently. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/uk_to_launch_early_access_to_drugs_plan_1001654Can pharma prove that being patient centric is more than just a fad? - Magazine Article - PharmaTimes
by Katrina Megget
www.pharmatimes.com/magazine/2018/may_2018/walking_the_patient_centric_talkThe anticipated positive decision for AstraZeneca’s anticlotting drug Brilinta (ticagrelor) in the USA has not materialised after regulators announced they wanted more information. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/brilinta_decision_delayed_again_981297The swine flu pandemic has been named as the “most ambitious scam and corruption of our time” after pharma has been found to be in bed with the World Health Organisation. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/swine_flu_labelled_a_conspiracy_984175Janssen-Cilag is to appeal the UK decision to restrictaccess to its multiple myeloma drug Velcade (bortezomib). - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/janssen-cilag_appeals_velcade_decision_982529
